Professional Documents
Culture Documents
Drug Delivery by Nano
Drug Delivery by Nano
By
ALI MOHAMMED HAMZA NASER
Supervised
By
Assist. Prof. Dr. Talib M. Albayati
Drug Delivery
A drug delivery system (DDS) is defined as a formulation or a device that enables
the introduction of a therapeutic substance in the body and improves its efficacy
and safety by controlling the rate, time, and place of release of drugs in the body.
1 2 3
microporous, macroporous
mesoporous,
have pore have pore
have pores in
size smaller size larger
the size
than 2 nm than 50 nm
range of 2
and 50 nm
Mesoporous Silica
Mesoporous silica nanoparticles (MSN) have been broadly applied in the areas of catalysis,
adsorption and separation processes. More recently, these ordered mesoporous materials have been
used also as matrices as storage vehicles in controlled drug delivery systems owing to their large
surface areas, tunable pore sizes, good biocompatibility and facile surface functionalization. The
making of these materials interesting as drug delivery carrier due to its good properties such as
zero premature release, high loading capacity of the drug, tailored drug release, high
bioavailability, enhanced the rate of dissolution and targeting the desired cells.
A two – dimensional
channel
Magnetic
Higher bioavailability
SBA-15
Increasing efficiency of
mesoporous silica
Modification the surface of SBA-15 by magnetic (Fe/SBA-15) with different loading ratio
2 (0.5%,1%,2%,3%) of pour volume of mesoporous(SBA-15)
Characterizations of (SBA-15 & Fe/SBA-15) by means of FT-IR, TGA, XRD, SEM and BET
3 surface area.
Nystatin and Meloxicam pharmaceutical compound will be loaded into the pores and surface
4 of mesoporous silica as drug delivery system by adsorption process from solution
5 Study the time of release(desorption) of the pharmaceutical compounds from the surface
mesoporous (SBA-15 and Fe/SBA-15)
7 Validation and optimization the data of drugs loading by using Statistical Experimental Design.
Synthesis of SBA-15
Modification of SBA-15
X-Ray Diffraction (XRD)
Scanning Electron Microscopy (SEM)
The Brunauer-Emmett-Teller Surface Area (SBET)
Thermal gravimetric analysis (TGA)
Fourier Transformed Infrared Spectra (FTIR)
In drug loading
experiments,
different
parameters that
affect on the
loading processes
were studied as
can be shown in
the table below:
Different conditions used for loading
Studied Variable (NYS by SBA-15) Range Units
Effect of pH 2 – 10 ــــــــ
Units
Studied Variable (MEL by SBA-15) Range
Effect of pH 2 - 10 ـــــــــــ
Effect of SBA-15 dosages 0.01 - 0.1 g
Effect of MEL
10 - 50 mg/l
Concentrations
Effect of Contact Time 4 - 72 h
Effect of pH 2 - 10 ـــــــــ
Effect of SBA-15 dosages 0.01 - 0.1 g
Effect of MEL
10 - 50 mg/l
Concentrations
Effect of Contact Time 4 - 72 h
Drug Release
The release of drugs
have done in
laboratory equipment
at given time intervals.
The suspension was
withdrawn by syringe
into a quartz cuvette.
The UV–Vis
spectrophotometer was
used to measure the
amount of the released
drugs NYS and MEL
at 305 nm and 362 nm
respectively
Drugs Release (desorption)
Variables and conditions used for release drugs
Media SBF (pH 7.4) SBF (pH 7.4) SBF (pH 7.4)
Temperature 37 oC 37 oC 37 oC
Si O2
d 100 a0 SBET Vp Dp Wt
Material Wt% Wt%
(nm) (nm) (m2/g) (cm3/g) (nm) (nm)
(EDX) (EDX)
Fe/SBA-
9.7 11.2 572.89 0.91 5.1 6.1 45.7 54.3
15
Scanning Electrons Microscope (SEM)
SBA-15
Fe/SBA-15
FTIR Spectra for SBA-15 &Fe/SBA-15
Thermal Gravimetric Analyses (TGA)
Nystatin loading (Adsorption)
1. Effect of pH 2. Effect of SBA-15 Dose
NYS@SBA-
2 0.14gm 30mg/l 24h 90.47
15
Nystatin Release (desorption)
Adsorption Isotherms Test
Materials
bT
qmax KL Kf KT
RL R2 N R2 kJ/m R2
mg/g l/mg mg/g l/mg
ol
NYS@SBA-
14.92 0.056 0.37 0.751 3.385 0.986 0.967 0.593 16.76 0.923
15
kinetic Release (desorption) of Nystatin
(a) First order Model, (b) Higuchi Model, (c) Korsmeyer_Peppas Model and (d) Weibull Model
Release kinetic parameters of Nystatin from SBA-15
drugs
K1 KH K (h-
R2 R2 R2 n R2 m
(h-1) (%h1/2) n)
NYS@SBA-15 0.993 0.0494 0.983 21.87 0.978 0.6089 17.9 0.995 0.7967
Statistical Experimental Design for Nystatin Drug Loading
Model of NYS drug
linear Quadratic
Drugs
R2 Adj-R2 Pred-R2 R2 Adj-R2 Pred-R2
Mathematical Model
𝐃𝐋% 𝐍𝐘𝐒@𝐒𝐁𝐀 − 𝟏𝟓
= 5.90 − 3.62 ∗ pH + 1.64 ∗ Dose − 0.95 ∗ Conce. +0.74 ∗ Time − 0.33
∗ pH 2 − 1.65 ∗ Dose 2 − 1.65 ∗ Conce. 2 − 1.01 ∗ Time 2
Effect of pH
Effect of SBA-15 and Fe/SBA-15 Dose
Effect of Initial MEL Concentration
Effect of Contact Time
Selecting of Operating Conditions for MEL Loading
Drug loading
31.81% 42.85%
efficiency %
Release (desorption)of Meloxicam
Adsorption Isotherms Test
(a) Langmuir, (b) Freundlich and (c) Temkin isotherms for MEL@SBA-15 and Fe/ SBA-15
Isotherm parameters for MEL loading with the correlation coefficient.
Materials
bT
qmax KL Kf KT kJ/mo
(L/mg RL R2 N R2 R2
(mg/g) (mg/g) l/mg
) l
MEL@SBA-15 16.05 0.031 0.51 0.9691 0.144 0.647 0.9942 0.6 15.88 0.9591
MEL@Fe/SBA-15 16.77 0.028 0.64 0.9349 0.079 0.582 0.9915 0.6 15.88 0.9349
kinetic Release of MEL (desorption)
Release kinetic parameters of Meloxicam from SBA-15 & Fe/SBA-15
Drugs
K1 KH K (h-
R2 R2 R2 n R2 m
(h-1) (%h1/2) n)
MEL@SBA-15 0.9845 0.0466 0.9772 21.598 0.9432 0.6549 16.6 0.9788 0.8376
MEL@Fe/SBA-15 0.9874 0.0257 0.9796 15.203 0.9494 0.7235 9.28 0.9538 0.3908
Statistical Experimental Design for Meloxicam Drug Loading
Model of MEL drug
linear Quadratic
Drugs
R2 Adj-R2 Pred-R2 R2 Adj-R2 Pred-R2
Mathematical Model
DL% MEL@SBA − 15
= 5.74 + 2.16 ∗ pH + 0.24 ∗ Dose + 0.55 ∗ Conce. +0.67 ∗ Time − 1.85 ∗ pH 2
− 0.72 ∗ Dose 2 − 0.62 ∗ Conce2 − 0.70 ∗ Time 2
DL% MEL@Fe SBA − 15
= 42.77 + 14.62 ∗ pH + 7.29 ∗ Dose + 16.90 ∗ Conce. +9.28 ∗ Time − 3.89 ∗ pH 2
− 11.07 ∗ Dose 2 − 14.42 ∗ Conce. 2 − 15.77 ∗ Time2
The significant parameters of MEL loading
Mean F p-value
Square Value Prob > F
Source
SBA-15 Fe/SBA15 SBA-15 Fe/SBA15 SBA-15 Fe/SBA15
The release of NYS drug from SBA-15 could reach up 87.97% after 18h
3 and the release of MEL drug from SBA-15&Fe/SBA-15 could reach up
to 85.76% , 78.13% after 18h, 24 h respectively. The release of drugs was
examined in SBF media of pH 7.4.
For Future study
1. Study the effect of temperature on
drug loading.
2. Using another methods to increase the
solubility of drugs such us use the ionic
liquids methods or using the green
solvent.
3. Using another kinds of mesoporous
materials like MCM-41 as a carrier for
Meloxicam drug.